Jacques Izopet to Hepatitis C
This is a "connection" page, showing publications Jacques Izopet has written about Hepatitis C.
Connection Strength
0.475
-
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Kidney Int. 2018 10; 94(4):663-673.
Score: 0.082
-
Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort. Antivir Ther. 2018; 23(4):307-314.
Score: 0.077
-
Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study. Transpl Infect Dis. 2017 Aug; 19(4).
Score: 0.075
-
A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS® TaqMan® HCV Test and RealTime HCV Assay. J Clin Virol. 2017 05; 90:18-25.
Score: 0.073
-
Hepatitis C virus and kidney disease. Clin Res Hepatol Gastroenterol. 2013 Sep; 37(4):328-33.
Score: 0.056
-
Treatment of hepatitis C virus infection after kidney transplantation. Contrib Nephrol. 2012; 176:87-96.
Score: 0.051
-
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology. 2002 Nov; 123(5):1494-9.
Score: 0.027
-
Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma. PLoS One. 2017; 12(4):e0174651.
Score: 0.018
-
Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation. 1995 May 27; 59(10):1426-31.
Score: 0.016